Ignite Creation Date:
2025-12-25 @ 12:53 AM
Ignite Modification Date:
2026-02-24 @ 10:55 AM
Study NCT ID:
NCT02725567
Status:
COMPLETED
Last Update Posted:
2023-09-07
First Post:
2016-03-14
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Ivacaftor in Subjects With Cystic Fibrosis Who Are Less Than 24 Months of Age and Have an Ivacaftor-Responsive CFTR Mutation
Sponsor:
Vertex Pharmaceuticals Incorporated
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-06-02
Start Date Type:
ACTUAL
Primary Completion Date:
2022-06-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-06-28
Completion Date Type:
ACTUAL
First Submit Date:
2016-03-14
First Submit QC Date:
None
Study First Post Date:
2016-04-01
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2023-06-27
Results First Submit QC Date:
None
Results First Post Date:
2023-09-07
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-08-14
Last Update Post Date:
2023-09-07
Last Update Post Date Type:
ACTUAL